Sterima has been acquired by Pollet Medical Group
The shareholders of Sterima have sold the company to Pollet Medical Group. Financial details have not been disclosed.
Headquartered in Belgium, Sterima offers full service sterilization solutions for hospitals and medical devices companies in the Benelux. Additionally, the company remains the trusted provider of nursing procedure sets with reusable instruments. Sterima also producers and distributes dialysis concentrate and related medical equipment to hospitals as a subcontractor for a large customer.
Pollet Medical Group is the medical division of Pollet Group and offers medical services and solutions for the healthcare industry. Pollet Group, a family-owned business, is active in the fields of water treatment, the pool business and medical services, and has companies across Europe, the Middle East and Africa.
Malysse-Sterima is a family business active in Belgium and the Netherlands. With more than 50 years of experience, the group is the leader in services for the healthcare sector.
Oaklins’ team in Belgium acted as financial advisor to the shareholders of Sterima in this transaction.
Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more